56
Ozempic’s Arrival in India – A Game‑Changer for Diabetes and Obesity
When Novo Nordisk finally introduced Ozempic to the Indian market, the move was more than a product launch; it signalled a paradigm shift for a country battling a surge in type‑2 diabetes and obesity. Priced at ₹2,200 per week for the initial 0.25 mg dose, the drug is positioned alongside insulin products, making it financially comparable for millions of patients.
Worth a look
previous post